Overview
Nandrolone decanoate, also known as nandrolone caprinate, is an alkylated anabolic steroid indicated in the management of anemia of renal insufficiency and as an adjunct therapy in the treatment of senile and postmenopausal osteoporosis. The process for creating esters of nandrolone was patented in Spain in 1959 and in 1960, it was described as having a long duration of action and strong anabolic effect compared to nandrolone and other esters. Nandrolone decanoate was granted FDA approval on 5 October 1962.
Background
Nandrolone decanoate, also known as nandrolone caprinate, is an alkylated anabolic steroid indicated in the management of anemia of renal insufficiency and as an adjunct therapy in the treatment of senile and postmenopausal osteoporosis. The process for creating esters of nandrolone was patented in Spain in 1959 and in 1960, it was described as having a long duration of action and strong anabolic effect compared to nandrolone and other esters. Nandrolone decanoate was granted FDA approval on 5 October 1962.
Indication
1.各种难治性贫血；2.创伤、慢性感染、营养不良等消耗性疾病；3.亦可用于骨质疏松症治疗。
Associated Conditions
- Chronic renal failure anemia
- Osteoporosis (Senile)
- Postmenopausal Osteoporosis
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/09/23 | Phase 4 | Not yet recruiting | |||
2024/06/17 | Phase 4 | Not yet recruiting | |||
2023/08/07 | Phase 2 | Recruiting | National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland | ||
2023/04/10 | Not Applicable | Recruiting | |||
2018/06/04 | Phase 2 | Completed | Morten Tange Kristensen PT, PhD | ||
2017/08/28 | Not Applicable | Completed | Hospital Erasto Gaertner | ||
2014/02/05 | Phase 1 | Completed | |||
2005/11/08 | Not Applicable | Completed | |||
2001/08/31 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| DECA-DURABOLIN INJECTION 25 mg/ml | SIN04300P | INJECTION | 25 mg/ml | 4/20/1990 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| DECA-DURABOLIN ORGAJECT 50mg/1mL injection syringe | 10655 | Medicine | A | 8/30/1991 | |
| DECA-DURABOLIN ORGAJECT 50mg/1mL injection ampoule | 280573 | Medicine | A | 3/8/2017 |